Radiofrequency vapor ablation for duodenal mucosal ablation in the treatment of type 2 diabetes: results from the first-in-human pilot study
DMA using the RFVA system is a simple through-the-scope procedure that appears safe, well tolerated, and feasible for the treatment of T2D. (Clinical trial registration number: NCT05887635.).
Authors
- Paulina Vignolo
- Andrea Telese
- Leonardo Rodriguez Grunert
- Apostolis Papaefthymiou (ORCID: https://orcid.org/0000-0002-3563-4973)
- Rehan Haidry (ORCID: https://orcid.org/0000-0002-4660-4382)
- Benjamin Norton (ORCID: https://orcid.org/0000-0003-2058-3162)
- Pablo Becerra Hoebel
- Alex Neiponice
Institutions
- Clínica Alemana (CL)
- Wellcome / EPSRC Centre for Interventional and Surgical Sciences (GB)
- Clínica MEDS (Chile) (CL)
- Cleveland Clinic London (GB)
- University College London (GB)
Publication Details
- Journal
- iGIE
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.igie.2025.03.008
- Citations
- 4
- Primary Topic
- Cardiac Arrhythmias and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.55